Verastem, Inc. (VSTM)
Verastem, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Verastem, Inc. (VSTM) is a Biotechnology company based in US with a market capitalization of $415.9M. Free cash flow was negative at -$137.5M. This page tracks VSTM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 78 employees · IPO Jan 27, 2012
Valuation
Valuation & price
$4.32as of May 17, 2026· -59.9% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
7.27
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$415.9M
Market cap
—
Revenue growth (YoY)
82.9%
Gross margin
-$137.5M
Free cash flow (USD)
-$128.1M
Net debt
Net cash position
94.1%
Share dilution
0/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
3
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 7, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJun 24, 2026Filing
Insider Sell $17KCalkins Daniel · Chief Financial Officer · $17.1K
- Insider sellJun 24, 2026Filing
Insider Sell $87KPaterson Dan · Director, President and CEO · $87.2K
- 8-K eventJun 23, 2026Filing
R&D Update Call Scheduled
- 8-K eventJun 17, 2026Filing
Clinical Trial Results
- 8-K eventMay 26, 2026Filing
Annual Meeting Results
- Quarterly reportMay 7, 2026Filing
10-Q Filed
- 8-K eventMay 7, 2026Filing
Corporate Presentation
- Insider sellMay 6, 2026Filing
Insider Sell $5KPaterson Dan · Director, President and CEO · $4.7K
Questions
Frequently asked questions
What is Verastem, Inc.'s market cap?
Verastem, Inc. (VSTM) has a market capitalization of $415.9M.
What is VSTM's P/E ratio?
A meaningful P/E ratio is not available for VSTM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is VSTM's price-to-book (P/B) ratio?
VSTM trades at 7.27 times book value per share.
Are insiders buying VSTM stock?
SEC Form 4 filings show no open-market insider buys at Verastem, Inc. in the last 90 days (3 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.